Page 332 - Read Online

Page 18 of 23 Monks et al. J Cancer Metastasis Treat 2019;5:24 I http://dx.doi.org/10.20517/2394-4722.2018.79

30. Gialamas SP, Petridou ET, Tseleni-Balafouta S, Spyridopoulos TN, Matsoukis IL, et al. Serum adiponectin levels and tissue expression of
adiponectin receptors are associated with risk, stage, and grade of colorectal cancer. Metabolism 2011;60:1530-8.
31. Fujisawa T, Endo H, Tomimoto A, Sugiyama M, Takahashi H, et al. Adiponectin suppresses colorectal carcinogenesis under the high-fat diet
condition. Gut 2008;57:1531-8.
32. Nagaraju GP, Aliya S, Alese OB. Role of adiponectin in obesity related gastrointestinal carcinogenesis. Cytokine Growth Factor Rev
2015;26:83-93.
33. Vetvik KK, Sonerud T, Lindeberg M, Lüders T, Størkson RH, et al. Globular adiponectin and its downstream target genes are up-regulated
locally in human colorectal tumors: ex vivo and in vitro studies. Metabolism 2014;63:672-81.
34. Tsukada T, Fushida S, Harada S, Terai S, Yagi Y, et al. Adiponectin receptor-1 expression is associated with good prognosis in gastric cancer.
J Exp Clin Cancer Res 2011;30:107.
35. Wu X, Chen P, Ou Y, Liu J, Li C, et al. Association of variants on ADIPOQ and AdipoR1 and the prognosis of gastric cancer patients after
gastrectomy treatment. Mol Biol Rep 2015;42:355-61.
36. Yamamoto H, Maeda K, Uji Y, Tsuchihashi H, Mori T, et al. Association between Reduction of Plasma Adiponectin Levels and Risk of
Bacterial Infection after Gastric Cancer Surgery. PLoS One 2013;8:e56129.
37. Howard JM, Cathcart MC, Healy L, Beddy P, Muldoon C, et al. Leptin and adiponectin receptor expression in oesophageal cancer. Br J
Surg 2014;101:643-52.
38. Rubenstein JH, Kao JY, Madanick RD, Zhang M, Wang M, et al. Association of adiponectin multimers with Barrett’s oesophagus. Gut
2009;58:1583-9
39. Ye J, Jia J, Dong S, Zhang C, Yu S, et al. Circulating adiponectin levels and the risk of breast cancer. Eur J Cancer Prev 2014;23:158-65.
40. Körner A, Pazaitou-Panayiotou K, Kelesidis T, Kelesidis I, Williams CJ, et al. Total and high-molecular-weight adiponectin in breast cancer:
in vitro and in vivo studies. J Clin Endocrinol Metab 2007;92:1041-8.
41. Shahar S, Salleh RM, Ghazali AR, Koon PB, Mohamud WN. Roles of adiposity, lifetime physical activity and serum adiponectin in
occurrence of breast cancer among Malaysian women in Klang Valley. Asian Pac J Cancer Prev 2010;11:61-6.
42. Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, et al. Association of serum adiponectin levels with breast cancer risk. Clin Cancer
Res 2003;9:5699-704.
43. Chen DC, Chung YF, Yeh YT, Chaung HC, Kuo FC, et al. Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer
Lett 2006;237:109-14.
44. Oh SW, Park CY, Lee ES, Yoon YS, Lee ES, et al. Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a
cohort study. Breast Cancer Res 2011;13:R34.
45. Gaudet MM, Falk RT, Gierach GL, Lacey JV, Graubard BI, et al. Do adipokines underlie the association between known risk factors and
breast cancer among a cohort of United States women? Cancer Epidemiol 2010;34:580-6.
46. Nagaraju GP, Rajitha B, Aliya S, Kotipatruni RP, Madanraj AS, et al. The role of adiponectin in obesity-associated female-specific
carcinogenesis. Cytokine Growth Factor Rev 2016;31:37-48.
47. Zheng Q, Wu H, Cao J. Circulating adiponectin and risk of endometrial cancer. PLoS One 2015;10:e0129824.
48. Dal Maso L, Augustin LS, Karalis A, Talamini R, Franceschi S, et al. Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol
Metab 2004;89:1160-3.
49. Cong L, Gasser J, Zhao J, Yang B, Li F, et al. Human adiponectin inhibits cell growth and induces apoptosis in human endometrial
carcinoma cells, HEC-1-A and RL95-2. Endocr Relat Cancer 2007;14:713-20.
50. Benaitreau D, Dieudonné MN, Dos Santos E, Leneveu MC, Mazancourt Pd, et al. Antiproliferative effects of adiponectin on human
trophoblastic cell lines JEG-3 and BeWo1. Biol Reprod 2009;80:1107-14.
51. Ohbuchi Y, Suzuki Y, Hatakeyama I, Nakao Y, Fujito A, et al. A lower serum level of middle-molecular-weight adiponectin is a risk factor
for endometrial cancer. Int J Clin Oncol 2014;19:667-73.
52. Stolzenberg-Solomon RZ, Weinstein S, Pollak M, Tao Y, Taylor PR, et al. Prediagnostic adiponectin concentrations and pancreatic cancer
risk in male smokers. Am J Epidemiol 2008;168:1047-55.
53. Dalamaga M, Migdalis I, Fargnoli JL, Papadavid E, Bloom E, et al. Pancreatic cancer expresses adiponectin receptors and is associated with
hypoleptinemia and hyperadiponectinemia: a case-control study. Cancer Causes Control 2009;20:625-33.
54. Grote VA, Rohrmann S, Dossus L, Nieters A, Halkjaer J, et al. The association of circulating adiponectin levels with pancreatic cancer risk:
a study within the prospective EPIC cohort. Int J Cancer 2012;130:2428-37.
55. Kenner BJ, Go VLW, Chari ST, Goldberg AE, Rothschild LJ. Early detection of pancreatic cancer: the role of industry in the development
of biomarkers. Pancreas 2017;46:1238-41.
56. Spyridopoulos TN, Petridou ET, Skalkidou A, Dessypris N, Chrousos GP, et al. Low adiponectin levels are associated with renal cell
carcinoma: a case-control study. Int J Cancer 2007;120:1573-8.
57. Pinthus JH, Kleinmann N, Tisdale B, Chatterjee S, Lu JP, et al. Lower plasma adiponectin levels are associated with larger tumor size and
metastasis in clear-cell carcinoma of the kidney. Eur Urol 2008;54:866-74.
58. Horiguchi A, Ito K, Sumitomo M, Kimura F, Asano T, et al. Decreased serum adiponectin levels in patients with metastatic renal cell
carcinoma. Jpn J Clin Oncol 2008;38:106-11.
59. Liao LM, Schwartz K, Pollak M, Graubard BI, Li Z, et al. Serum leptin and adiponectin levels and risk of renal cell carcinoma. Obesity
2013;21:1478-85.
60. Burton A, Martin RM, Holly J, Lane JA, Donovan JL, et al. Associations of adiponectin and leptin with stage and grade of PSA-detected
prostate cancer: the ProtecT study. Cancer Causes Control 2013;24:323-34.
61. Dhillon PK, Penney KL, Schumacher F, Rider JR, Sesso HD, et al. Common polymorphisms in the adiponectin and its receptor genes,
adiponectin levels and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2011;20:2618-27.
62. Wang SN, Yang SF, Tsai HH, Lee KT, Yeh YT. Increased adiponectin associated with poor survival in hepatocellular carcinoma. J